Dapagliflozin and Metformin Hydrochloride (Dapagliflozin and Metformin Hydrochloride) — NDC 33342-409 by Macleods Pharmaceuticals
Dapagliflozin and Metformin Hydrochloride (Dapagliflozin and Metformin Hydrochloride) — NDC 33342-409 by Macleods Pharmaceuticals is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Dapagliflozin and Metformin Hydrochloride; Generic name: Dapagliflozin and Metformin Hydrochloride; Product
| Brand name | Dapagliflozin and Metformin Hydrochloride |
|---|---|
| Generic name | Dapagliflozin and Metformin Hydrochloride |
| Product NDC | 33342-409 |
| Labeler | Macleods Pharmaceuticals Limited |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active ingredients | DAPAGLIFLOZIN 10 mg/1; METFORMIN HYDROCHLORIDE 1000 mg/1 |
| Pharmacologic class | Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA] |
| Marketing category | ANDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →